150 Mg Erlotinib Tablets IP

Name: 150 Mg Erlotinib Tablets IP
Brand: NEETCO BIOPHARMA
Price: 2000 INR
Availability: InStock

Price 2000 INR/ Bottle

Get a Price/Quote

MOQ : 1 Bottle

150 Mg Erlotinib Tablets IP Specification

Salt Composition
Erlotinib Hydrochloride 150 mg

Indication
Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer

Dosage Form
Film-coated Tablet

Feature
Prescription only, Oral administration

Ingredients
Erlotinib Hydrochloride, Excipients

Application
Anticancer Therapy

Physical Color/Texture
White to off-white, round, film-coated tablet

Storage Instructions
Store below 30C, protect from moisture and light

Shelf Life
24 months

About 150 Mg Erlotinib Tablets IP

Introducing 150 Mg Erlotinib Tablets IP, a formidable and dominant choice in tyrosine kinase inhibitor therapy for oncology. Recognized as a laureate in anticancer treatment, this new release is available at the best price for distributors, exporters, and suppliers aiming to provide reliable access to vital medication. Each film-coated, white to off-white round tablet delivers 150 mg of Erlotinib Hydrochloride. Offered in secure Alu-Alu blister packaging, each box contains 30 tablets (variation possible). For prescription-only use-exclusively on an oncologist's advice. Ideal for NSCLC and pancreatic cancer, this product is available for prompt, nationwide supply from India.

Comprehensive Anticancer Application and Proper Usage

150 Mg Erlotinib Tablets IP is expertly formulated for use in the treatment of Non-Small Cell Lung Cancer (NSCLC) and pancreatic cancer, as directed by a qualified physician. As a trusted tyrosine kinase inhibitor, its domain is in prescription-based cancer therapy, administered orally. For optimal efficacy, it is to be used strictly according to medical instructions, ensuring the patient receives the full benefit of this laureate product in targeted oncological care.

Sample Policy and Swift Domestic Market Supply

150 Mg Erlotinib Tablets IP is backed by a transparent sample policy and assured supply capacity. We facilitate express shipping and aim for swift order completion to meet urgent demands in the domestic market. With a reliable distribution network, we can efficiently respond to both routine and special orders, ensuring healthcare providers across India have timely access to this prevalent anticancer solution. Our commitment: seamless, responsive service for all partners and clients.

FAQ's of 150 Mg Erlotinib Tablets IP:

Q: How should 150 Mg Erlotinib Tablets IP be administered?

A: 150 Mg Erlotinib Tablets IP should be taken orally, strictly as directed by a physician, ideally at least one hour before or two hours after eating. Use it only under a licensed oncologist's supervision.

Q: What is the primary use of this medication?

A: This tablet is primarily used for treating Non-Small Cell Lung Cancer (NSCLC) and pancreatic cancer as part of a prescribed anticancer therapy regimen.

Q: Where can I purchase 150 Mg Erlotinib Tablets IP?

A: This medicine is available through authorized distributors, suppliers, and traders in India. Since it is a prescription-only drug, it must be dispensed by retail pharmacists upon presentation of an oncologist's prescription.

Q: When is the right time to start this treatment?

A: Begin treatment only after consultation and diagnosis by an oncologist, who will determine the appropriate time and dose schedule based on your specific condition.

Q: What are the storage instructions for these tablets?

A: Store the tablets below 30C, and protect them from moisture and light to preserve their effectiveness throughout the 24-month shelf life.

Q: How does the supply process ensure quick delivery?

A: Express shipping and a streamlined order completion process facilitate fast and reliable delivery across the domestic market, ensuring immediate availability when needed.

Tell us about your requirement